These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 26967391)
1. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer. Gebauer F; Gelis S; Zander H; Meyer KF; Wolters-Eisfeld G; Izbicki JR; Bockhorn M; Tachezy M Oncotarget; 2016 Apr; 7(15):20945-52. PubMed ID: 26967391 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer. Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer. Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients. Fan J; Yu H; Lv Y; Yin L Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
6. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer. Mo D; He F Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer. Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968 [TBL] [Abstract][Full Text] [Related]
8. High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer. Lu J; Wang Y; Yan M; Feng P; Yuan L; Cai Y; Xia X; Liu M; Luo J; Li L Oncotarget; 2016 Jul; 7(27):41758-41766. PubMed ID: 27248178 [TBL] [Abstract][Full Text] [Related]
9. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer. Wang SY; Li Y; Jiang YS; Li RZ Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091 [TBL] [Abstract][Full Text] [Related]
10. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis. Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer. Sun B; Liu HF; Ding Y; Li Z Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum miR-25 in non-small-cell lung cancer. Li J; Yu M; Liu Z; Liu B Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763 [No Abstract] [Full Text] [Related]
14. Prognostic significance of serum sMICA levels in non-small cell lung cancer. Wang LP; Niu H; Xia YF; Han YL; Niu P; Wang HY; Zhou QL Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2226-30. PubMed ID: 26166647 [TBL] [Abstract][Full Text] [Related]
15. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer. Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483 [TBL] [Abstract][Full Text] [Related]
16. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer. Wang K; Dong L; Fang Q; Xia H; Hou X Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561 [TBL] [Abstract][Full Text] [Related]
17. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer. Jiang AG; Chen HL; Lu HY BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656 [TBL] [Abstract][Full Text] [Related]
18. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750 [TBL] [Abstract][Full Text] [Related]
19. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients. Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686 [TBL] [Abstract][Full Text] [Related]
20. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]